Now this is an interesting one, a new PSMA tracer which appears to greatly outperform 68Ga-PSMA-11 for biochemical recurrence. We discuss 64Cu-SAR-bisPSMA with Professor Louise Emmett (Nuclear Medicine Physician, Sydney), and Dr Matt Roberts (Urologist, Brisbane), which they compared head to head with trusty old 68Ga-PSMA-11 in the Co-PSMA trial, just published in European Urology.

With usual hosts Declan Murphy and Renu Eapen.

This Themed Podcast is supported by our new Bronze Partners, Clarity Pharmaceuticals

Even better on our YouTube channel

Links:
Co-PSMA trial in European Urology 

Clarity Pharmaceuticals website 

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Professor Declan Murphy & Dr Renu Eapen. Innehållet i podden är skapat av Professor Declan Murphy & Dr Renu Eapen och inte av, eller tillsammans med, Poddtoppen.